BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Penn Medicine And Life Line Screening Collaborate On Peripheral Artery Disease Study


1/17/2007 9:19:28 AM

CLEVELAND, Jan. 17 /PRNewswire/ -- The University of Pennsylvania Health System and Life Line Screening, the nation's largest provider of mobile preventive health screenings, are collaborating to identify and recruit patients with Peripheral Arterial Disease (P.A.D.) for a pilot study on the causes and prevention of this common yet under-treated vascular disease.

"P.A.D. has a strong correlation to coronary heart disease and carries a higher risk of stroke and heart attack," says Dr. Emile R. Mohler III, director of Vascular Medicine, University of Pennsylvania Health System. "As we develop a greater understanding of how P.A.D. progresses, we'll be better equipped to help patients by determining when and how to treat them."

The research, using non-invasive ultrasound imaging, will begin to pinpoint the exact cause and progression of claudication, or outward symptoms of P.A.D. Cramps, tiredness or pain in the legs and buttocks can manifest when blood flow is restricted by atherosclerosis (hardening of the arteries).

Life Line Screening, which has screened over 4.5 million people since 1993 for stroke risk and vascular disease, will inform participants with P.A.D. in the Philadelphia and San Diego areas that they can volunteer for the study by contacting the University of Pennsylvania directly. Life Line Screening will not release private medical information to the university or receive compensation for referrals.

"Life Line Screening's primary goal is to help Americans live long, healthy, independent lives by reducing the incidence of stroke and vascular disease through early detection," said Dr. Andrew Manganaro, vascular surgeon and Medical Director for Life Line Screening. "Since we screen for vascular disease daily across the country, we're an ideal conduit for patient referrals to the Penn P.A.D. study.

"Approximately one in twenty Americans over 50 has P.A.D. and up to 75 percent of them don't know it," he said. "I urge all Americans over 50, and especially those with risk factors, to be screened for P.A.D. It's a serious condition that if left undetected and untreated can lead to a deadly or disabling stroke or heart attack."

Study participants may be eligible for a stipend to cover travel costs. To participate, contact Penn at 215-614-0090.

For more information about Life Line Screening call 877-237-1272 or visit www.lifelinescreening.com.

Life Line Screening

CONTACT: Phyllis Laorenza-Linnehan of KOGS Communication, +1-781-245-7773x.105, or phyllis@kogspr.com, for Life Line Screening



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES